Global HER2-Negative breast cancer market expected to generate around US $4 billion by 2019, says Technavio
HER2-Breast Cancer: Kay market research findings Emerging new therapies and procedures Rise in public awareness and patient assistance programs Technavio has added a new market research report on the global HER2 negative breast cancer market, to its breast cancer portfolio. Technavio’s market research analysts estimate the HER2 negative breast cancer market to grow at…
